ECM
IRWD icon

Everence Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Everence Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,850
Closed -$115K – 928
2024
Q3 		$115K Buy
27,850
+7,420
+36% +$39.9K 0.01% 741
2024
Q2 		$158 Hold
20,430
– – 0.01% 714
2024
Q1 		$178 Hold
20,430
– – 0.01% 733
2023
Q4 		$234K Hold
20,430
– – 0.02% 654
2023
Q3 		$197 Buy
20,430
+10,340
+102% +$101K 0.02% 679
2023
Q2 		$110K Hold
10,090
– – 0.01% 714
2023
Q1 		$106 Sell
10,090
-34,960
-78% -$392K 0.01% 735
2022
Q4 		$558 Sell
45,050
-9,440
-17% -$107K 0.05% 336
2022
Q3 		$565K Hold
54,490
– – 0.05% 313
2022
Q2 		$628K Buy
+54,490
New +$642K 0.06% 272

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Everence Capital Management's IRWD Position: Q4 2024 in Review

Everence Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 27,850 shares — an estimated $115K sold.

Everence Capital Management first reported a position in IRWD in Q2 2022 and held it in 10 quarters. The position peaked at $628K in Q2 2022. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Everence Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Everence Capital Management sold 27,850 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $115K.
  • Everence Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 10 quarters.
  • Everence Capital Management's Ironwood Pharmaceuticals position peaked at $628K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.